CLINICAL ROLE -
August 28th 2025
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
Biosimilars can be a more affordable and accessible treatment option for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
August 25th 2025
A systematic review and meta-analysis revealed key insights into lipid parameters in patients with systemic sclerosis.
August 21st 2025
New research confirms that switching from tocilizumab to its biosimilar, Avtozma, maintains efficacy and safety in patients with rheumatoid arthritis (RA).
July 29th 2025
The supplements were also linked to improvements in pain and disease activity markers.
Rheumatoid Arthritis
Read More
Rheumatoid Arthritis Watch
Achieving Physical Activity Goals Benefits RA Patients
Findings from a new study show that success in reaching physical goals is associated with reduced arthritis pain and increased quality of life.
Pregnancy OK with Rheumatoid Arthritis